There are situations where there is no reference price or value for a biological asset; in
this circumstance the fair value will be calculatedas updated value of assets’ net expected
cash flows. This standard implies that there is always a realistic way of determining fair
value; if not, one will consider applying the amortized cost as replacement for the fair value.